Related content

Diagnostic value of asymmetric striatal D₂ receptor upregulation in Parkinson’s disease: an [¹²³I]IBZM and [¹²³I]FP-CIT SPECT study

By Verstappen C.   Bloem B.   Haaxma C.   Oyen W.   Horstink M.  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 34, Iss. 4, 2007-04 ,pp. : 502-507

Springer Publishing Company

Access to resources Recommend Favorite

Quantification of [¹²³I]FP-CIT SPECT brain images: an accurate technique for measurement of the specific binding ratio

By Tossici-Bolt Livia   Hoffmann Sandra   Kemp Paul   Mehta Rajnikant   Fleming John  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 33, Iss. 12, 2006-12 ,pp. : 1491-1499

Springer Publishing Company

Access to resources Recommend Favorite

No significant effects of single intravenous, single oral and subchronic oral administration of acetylcholinesterase inhibitors on striatal [¹²³I]FP-CIT binding in rats

By Knol R.   Bruin K.   Eck-Smit B.   Booij J.  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 35, Iss. 3, 2008-03 ,pp. : 598-604

Springer Publishing Company

Access to resources Recommend Favorite

Regional CBF changes in Parkinson’s disease: a correlation with motor dysfunction

By Hsu Jung-Lung   Jung Tzyy-Ping   Hsu Chien-Yeh   Hsu Wei-Chih   Chen Yen-Kung   Duann Jeng-Ren   Wang Han-Cheng   Makeig Scott  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 34, Iss. 9, 2007-09 ,pp. : 1458-1466

Springer Publishing Company

Access to resources Recommend Favorite

Dopamine transporter SPECT using fast kinetic ligands: ¹²³I-FP-β-CIT versus ^99mTc-TRODAT-1

By Laere K.   Ceuninck L.   Dom R.   Eynden J.   Vanbilloen H.   Cleynhens J.   Dupont P.   Bormans G.   Verbruggen A.   Mortelmans L.  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 31, Iss. 8, 2004-08 ,pp. : 1119-1127

Springer Publishing Company

Access to resources Recommend Favorite